文献速递流行病学与生物统计临床试验与 GCP

使用图方法进行多重性调整的临床试验样本量优化

Sample size optimization for clinical trials using graphical approaches for multiplicity adjustment.
PubMed 文献 · Stat Med · 2023-09-20

针对多终点临床试验图方法中初始权重与转移概率缺乏理论指导的问题,提出在边际功效设定下优化样本量的统计方法,证明常用图方法(如将全部初始权重置于单一终点)为次优,并证明在连续性假设下存在使所有边际功效恰好等于预设值的最优解,用两个假设性试验设计示例说明应用。

要点

  • 提出在图方法下基于初始权重与转移概率优化样本量的统计方法。
  • 证明将全部初始权重置于单一终点等常用图方法为次优。
  • 方法适用于单臂试验和随机对照试验,终点可为连续、二分类或混合类型。

核心结论

  • 提出在图方法下优化初始权重与转移概率以最小化满足功效要求所需样本量的统计方法。
  • 证明一些常用图方法(如将全部初始权重置于一个终点)为次优。
  • 证明在连续性假设下存在使所有边际功效恰好置于预设值的最优解。

研究设计与样本

  • 方法学研究,提出在图方法下基于边际功效设定优化样本量的统计方法。
  • 方法可用于单臂试验和随机对照试验,终点类型包括连续、二分类或混合类型。
  • 通过两个假设性临床试验设计示例说明方法在不同场景下的应用。

主要发现

  • 结果首先针对两个终点的设计呈现,并进一步推广至三个或更多终点。
  • 证明将全部初始权重置于一个终点等常用图方法为次优。
  • 证明在连续性假设下存在使所有边际功效恰好置于预设值的最优解。

临床怎么用

  • 研究结果有助于指导图方法的设计和临床试验的样本量计算。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Graphical approach provides a useful framework for multiplicity adjustment in clinical trials with multiple endpoints. When designing a graphical approach, initial weight and transition probability for the endpoints are often assigned based on clinical importance. For example, practitioners may prefer putting more weights on some primary endpoints. The clinical preference can be formulated as a constrain in the sample size optimization problem. However, there has been a lack of theoretical guidance on how to specify initial weight and transition probability in a graphical approach to meet the clinical preference but at the same time to minimize the sample size needed for a power requirement. To fill this gap, we propose statistical methods to optimize sample size over initial weight and transition probability in a graphical approach under a common setting, which is to use marginal power for each endpoint in a trial design. Importantly, we prove that some of the commonly used graphical approaches such as putting all initial weights on one endpoint are suboptimal. Our methods are flexible, which can be used for both single-arm trials and randomized controlled trials with either continuous or binary or mixed types of endpoints. Additionally, we prove the existence of optimal solution where all marginal powers are placed exactly at the prespecified values, assuming continuity. Two hypothetical clinical trial designs are presented to illustrate the application of our methods under different scenarios. Results are first presented for a design with two endpoints and are further generalized to three or more endpoints. Our findings are helpful to guide the design of a graphical approach and the sample size calculation in clinical trials.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Zhang F, Gou J. Sample size optimization for clinical trials using graphical approaches for multiplicity adjustment. Stat Med. 2023. PMID: 37727983. doi:10.1002/sim.9909

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。